| The role of sirtuins in antioxidant and redox signaling CK Singh, G Chhabra, MA Ndiaye, LM Garcia-Peterson, NJ Mack, ... Antioxidants & redox signaling 28 (8), 643-661, 2018 | 630 | 2018 |
| Plk1 inhibitors in cancer therapy: from laboratory to clinics REA Gutteridge, MA Ndiaye, X Liu, N Ahmad Molecular cancer therapeutics 15 (7), 1427-1435, 2016 | 362 | 2016 |
| Circadian rhythm connections to oxidative stress: implications for human health M Wilking, M Ndiaye, H Mukhtar, N Ahmad Antioxidants & redox signaling 19 (2), 192-208, 2013 | 305 | 2013 |
| Resveratrol and cancer: Challenges for clinical translation CK Singh, MA Ndiaye, N Ahmad Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1852 (6 …, 2015 | 297 | 2015 |
| The grape antioxidant resveratrol for skin disorders: promise, prospects, and challenges M Ndiaye, C Philippe, H Mukhtar, N Ahmad Archives of biochemistry and biophysics 508 (2), 164-170, 2011 | 273 | 2011 |
| Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells M Kunnimalaiyaan, AM Vaccaro, MA Ndiaye, H Chen Journal of biological Chemistry 281 (52), 39819-39830, 2006 | 161 | 2006 |
| Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells M Kunnimalaiyaan, AM Vaccaro, MA Ndiaye, H Chen Molecular cancer therapeutics 6 (3), 1151-1158, 2007 | 118 | 2007 |
| Resveratrol in cancer management: where are we and where we go from here? M Ndiaye, R Kumar, N Ahmad Annals of the New York Academy of Sciences 1215 (1), 144-149, 2011 | 108 | 2011 |
| Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002 M Kunnimalaiyaan, M Ndiaye, H Chen Surgery 140 (6), 1009-1015, 2006 | 88 | 2006 |
| Skin, reactive oxygen species, and circadian clocks MA Ndiaye, M Nihal, GS Wood, N Ahmad Antioxidants & redox signaling 20 (18), 2982-2996, 2014 | 73 | 2014 |
| PLK1 inhibition-based combination therapies for cancer management S Su, G Chhabra, CK Singh, MA Ndiaye, N Ahmad Translational oncology 16, 101332, 2022 | 55 | 2022 |
| Prostate cancer chemoprevention by natural agents: Clinical evidence and potential implications G Chhabra, CK Singh, MA Ndiaye, S Fedorowicz, A Molot, N Ahmad Cancer letters 422, 9-18, 2018 | 55 | 2018 |
| SIRT6 histone deacetylase functions as a potential oncogene in human melanoma LM Garcia-Peterson, MA Ndiaye, CK Singh, G Chhabra, W Huang, ... Genes & cancer 8 (9-10), 701, 2017 | 48 | 2017 |
| Sirtuins in skin and skin cancers LM Garcia-Peterson, MJ Wilking-Busch, MA Ndiaye, CGA Philippe, ... Skin Pharmacology and Physiology 30 (4), 216-224, 2017 | 48 | 2017 |
| Melanoma chemoprevention: Current status and future prospects G Chhabra, MA Ndiaye, LM Garcia‐Peterson, N Ahmad Photochemistry and photobiology 93 (4), 975-989, 2017 | 45 | 2017 |
| Numb regulates stability and localization of the mitotic kinase PLK1 and is required for transit through mitosis TL Schmit, M Nihal, M Ndiaye, V Setaluri, VS Spiegelman, N Ahmad Cancer research 72 (15), 3864-3872, 2012 | 38 | 2012 |
| Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer MR Cook, J Luo, M Ndiaye, H Chen, M Kunnimalaiyaan The American journal of surgery 199 (3), 315-318, 2010 | 38 | 2010 |
| Lithium inhibits carcinoid cell growth in vitro DY Greenblatt, M Ndiaye, H Chen, M Kunnimalaiyaan American journal of translational research 2 (3), 248, 2010 | 38 | 2010 |
| Sirtuin deacetylases: a new target for melanoma management MJ Wilking, CK Singh, M Nihal, MA Ndiaye, N Ahmad Cell Cycle 13 (18), 2821-2826, 2014 | 35 | 2014 |
| Quercetin–resveratrol combination for prostate cancer management in TRAMP mice CK Singh, G Chhabra, MA Ndiaye, IA Siddiqui, JE Panackal, CA Mintie, ... Cancers 12 (8), 2141, 2020 | 34 | 2020 |
Nihal AhmadUniversity of Wisconsin-Madison在 wisc.edu 的电子邮件经过验证
